UCSF's basic research over nearly two decades has led to the first novel antitoxin to treat botulism in nearly a century – becoming the first recombinant human therapy to target one of the most dangerous substances known to man and offering a new defense against bioterrorism.
March 28, 2011
UCSF School of Pharmacy Dean Mary Anne Koda-Kimble issued an update on the school's accomplishments, faculty awards and other campus news.
February 03, 2011
UCSF neurosurgeons and an MRI physicist have pioneered a faster, more accurate and less invasive surgical technique for treating patients with movement disorders, potentially changing the future of neurosurgery.
December 15, 2010
Weight gain and environmental pollutants might be linked, an award-winning worm researcher suggests.
December 02, 2010
UCSF Chancellor Sue Desmond-Hellmann named campus leader Renee Navarro, past director of academic diversity, as the University’s first vice chancellor of diversity and outreach.
November 10, 2010
Paul Ortiz de Montellano has been appointed associate dean of research in the UCSF School of Pharmacy, a key advisor to the dean on campus, national and international science opportunities issues and trends.
July 21, 2010
Larissa Podust, PhD, is working on a new drug for Chagas disease, a neglected scourge.
July 02, 2010
Antibiotic-resistant Staph infection is not the only emerging bacterial threat. Now a different bug -- Clostridium difficile -- is gaining strength.
June 16, 2010
James McKerrow, leader of the Sandler Center for Drug Discovery at UCSF, was honored with the 2009 Mendel Medal for his work identifying the vulnerabilities of disease-causing parasites and for devising new strategies to fight them.
June 03, 2010
UCSF’s Renee Navarro and Amy Levine, both champions of diversity, played pivotal roles in the recent UC Diversity Pipeline Initiative, which encourages female students to pursue careers as faculty in the health sciences.